Table 2.
Virological suppression at on-treatment time-points (n = 92)
| Follow-up (mo) | 0 | 6 | 12 | 18 | 24 | 30 | 36 |
| Patients with viral load n (%) | 92 (100) | 74 (80.4) | 65 (70.7) | 58 (63) | 46 (50) | 30 (32.6) | 28 (30.4) |
| Virological suppression n (%) | 18 (19.6) | 41 (55.4) | 45 (69.2) | 46 (79.3) | 37 (80.4) | 26 (86.7) | 25 (89.3) |
“Patients with viral load” refers to the number of patients at each time point who had an available HBV DNA reading. “Virological suppression” refers to the number of patients with HBV DNA < 20 IU/mL. HBV: Hepatitis B virus.